United States Antimony Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 12, 2026, reporting a net loss of $9,526,056 for the three months ended September 30, 2026.

Key Highlights

  • Quarterly net loss: The company reported a net loss of $9,526,056 for the three months ended September 30, 2026, compared to a net loss of $4,780,700 in the same period of 2025.
  • Nine-month net loss: For the nine months ended September 30, 2026, the net loss totaled $20,710,256, versus $4,052,621 for the same period of 2025.
  • Quarterly revenue: Revenues were $10,133,437 for the three months ended September 30, 2026, up from $8,701,951 in the prior-year quarter.
  • Total assets: Total assets were $190,283,461 as of September 30, 2026, compared to $153,925,669 as of December 31, 2025.
  • Unrealized loss on equity securities: The company recorded an unrealized loss on investment in equity securities of $3,845,926 for the three months ended September 30, 2026.
  • Shares outstanding: As of November 9, 2026, there were 149,329,434 shares of $0.01 par value common stock outstanding.
  • Inventory growth: Inventories increased to $28,126,132 as of September 30, 2026, from $12,522,009 as of December 31, 2025.

United States Antimony Q3 2026 Financial Results: Revenue Rises as Operating Losses Widen

According to the filing, United States Antimony Corporation (NYSE:UAMY) reported quarterly revenues of $10,133,437 for the three months ended September 30, 2026, a rise from $8,701,951 in the same quarter of 2025. Despite the revenue increase, gross profit for the quarter was $4,294,142, up from $2,013,442 in the prior-year period. However, total operating expenses reached $10,277,487 for the three months ended September 30, 2026, resulting in a loss from operations of $5,983,345, compared to a loss from operations of $4,917,182 in the same quarter of 2025.

The company disclosed that mineral exploration expenses were $4,407,039 for the three-month period ended September 30, 2026, compared to $1,037,637 in the prior-year quarter. Salaries and benefits totaled $3,218,465 for the quarter. For the nine months ended September 30, 2026, total operating expenses were $26,468,346 versus $11,761,900 for the nine months ended September 30, 2025. The nine-month loss from operations was $20,481,440, compared to $4,539,183 in the prior-year nine-month period. Net loss per share, both basic and diluted, was $(0.06) for the three months ended September 30, 2026, and $(0.14) for the nine months ended September 30, 2026.

On the balance sheet, total assets grew to $190,283,461 as of September 30, 2026, from $153,925,669 as of December 31, 2025. Property, plant and equipment, net increased to $61,865,400 from $42,374,839 over the same period. Total liabilities rose to $18,338,326 from $12,970,480. The accumulated deficit widened to $66,198,805 as of September 30, 2026, from $45,488,549 as of December 31, 2025. Total stockholders' equity was $171,945,135 as of September 30, 2026. The company reported cash and cash equivalents of $30,053,201 as of September 30, 2026, versus $30,494,320 as of December 31, 2025.

What Was Disclosed

United States Antimony Corporation disclosed its unaudited condensed consolidated financial results for the three and nine months ended September 30, 2026, including a quarterly net loss of $9,526,056, revenues of $10,133,437, total assets of $190,283,461, and 149,329,434 shares outstanding as of November 9, 2026.